About 311,000 results
Open links in new tab
  1. Amneal Reports Third Quarter 2025 Financial Results

    Oct 30, 2025 · Net revenue in the third quarter of 2025 was $785 million, an increase of 12% compared to $702 million in the third quarter of 2024. Specialty net revenue increased 8% …

  2. Amneal Q3 2025 slides: Revenue up 12% as specialty products …

    Oct 30, 2025 · Amneal Pharmaceuticals Inc. (NYSE:AMRX) presented its third quarter 2025 results on October 30, showcasing continued momentum across its diversified business …

  3. Amneal Reports Certain Preliminary Second Quarter 2025

    Jun 30, 2025 · Unaudited Preliminary Financial Results for the Second Quarter Ended June 30, 2025. “Amneal continued to deliver robust growth and further deleveraging underscoring the …

  4. Amneal Pharmaceuticals Reports Q3 2025 Financial Results and …

    Oct 30, 2025 · Amneal has updated its full-year guidance for 2025, projecting net revenue between $3.0 billion and $3.1 billion, with adjusted EBITDA and operating cash flow estimates …

  5. Amneal Pharmaceuticals Announces FY25 Revenue Outlook …

    Feb 28, 2025 · (RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX), Friday announced financial outlook for the fiscal year 2025. The company sees revenue in the range of $3.0 billion to $3.1 …

  6. Amneal (NASDAQ:AMRX) Beats Q3 Sales Expectations, Stock Soars

    Oct 30, 2025 · Pharmaceutical company Amneal Pharmaceuticals (NASDAQ: AMRX) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 11.7% year on …

  7. Amneal Q3 2025 Earnings: Profit of $2.4M, Revenue $784.5M

    Oct 30, 2025 · Amneal Pharmaceuticals announced a profitable Q3 2025 with net income of $2.4M and revenue of $784.5M, exceeding Wall Street forecasts and reversing last year's loss.

  8. Why Amneal Pharmaceuticals (AMRX) Is Up 16.6% After …

    6 days ago · In recent days, Amneal Pharmaceuticals reported third quarter earnings showing a return to profitability alongside year-over-year sales growth, maintained its 2025 full-year …

  9. Why Amneal Pharmaceuticals (AMRX) Is Up 16.6% After …

    6 days ago · In recent days, Amneal Pharmaceuticals reported third quarter earnings showing a return to profitability alongside year-over-year sales growth, maintained its 2025 full-year …

  10. Amneal Reports Third Quarter 2025 Financial Results

    Oct 30, 2025 · Amneal Reports Third Quarter 2025 Financial Results. Oops, something went wrong. Skip to navigation Skip to main content Skip to right column . News. Today's news. US. …